comparemela.com

Latest Breaking News On - Prnewswire cardiff oncology inc - Page 7 : comparemela.com

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joyce allairelifesciAmy jobeCardiff oncology incPrnewswire cardiff oncology incCardiff oncologyNasdaq listing ruleInc cardiff oncologyPolo like kinaseOncology contactVicki kelemenchief operating

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incCardiff oncologyNasdaq listing rulePolo like kinaseOncology contact

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incCardiff oncologyNasdaq listing rulePolo like kinaseOncology contact

Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

United statesHeinz josef lenzActa oncologicaMark erlanderAmy jobeVicki kelemenJoyce allaireKatherinel ruffnerCardiff oncology incInova schar cancer instituteCancer centerPrnewswire cardiff oncology incExchange commissionKansas university medical centerLifesci communicationsNorris comprehensive cancer center

Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

United statesHeinz josef lenzActa oncologicaMark erlanderAmy jobeVicki kelemenJoyce allaireKatherinel ruffnerCardiff oncology incInova schar cancer instituteCancer centerPrnewswire cardiff oncology incExchange commissionKansas university medical centerLifesci communicationsNorris comprehensive cancer center

vimarsana © 2020. All Rights Reserved.